ANALYTICAL SUPPORT OF INNOVATIVE PHARMACEUTICAL DEVELOPMENT OF ANTIHYPERTENSIVE DRUGS
PDF

Як цитувати

Peleshok, K., Shulyak, N., Adaeze, E., Donkor, A., Oluwatobiloba, J., Fatma, A., Obianuju, F., & Agyemang, F. (2021). ANALYTICAL SUPPORT OF INNOVATIVE PHARMACEUTICAL DEVELOPMENT OF ANTIHYPERTENSIVE DRUGS. InterConf, (45). вилучено із https://ojs.ukrlogos.in.ua/index.php/interconf/article/view/10324
PDF

Посилання

Acelajado M. C., Hughes Z. H., Oparil S., Calhoun D. A. Treatment of resistant and refractory hypertension. Circ. Res. 2019; 124: 1061-1070.

Moffat A. C., Osselton M. D., Widdop B., Watts J. (Ed.), Clarke’s Analysis of Drugs and Poisons, fourth edition, Pharmaceutical Press, Lambeth High Street, London 2011, 1620-1622.

Kazakevic Yu, Lobruto R. The Book: HPLC for Practicing Scientist. John Wiley & Sons 2007, 206–227.

Peleshok K., Piponski M., Ajie E.A., Poliak O., Zarivna N., Denefil O., Logoyda L. Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment. Pharmacia. 2021; 68: 43–51.

Piponski M., Peleshok K., Logoyda L., Kravchuk L., Piatnochka V., Zakharchuk U. Efficient Validated HPLC/UV Method for Determination of Valsartan and Atenolol in Dosage Form And In Vitro Dissolution Studies. BRIAC. 2020;10: 6669-75.

Peleshok K., Piponski M., Kovalenko S., Ahmed H., Abdel‐Megied A., Ezike O. F., Logoyda L. New liquid chromatography assays for simultaneous quantification of antihypertensives atenolol and valsartan in their dosage forms. J Sep Sci. 2020; 44: 565-75.

International Conference on Harmonization (ICH) of technical requirements for registration of pharmaceuticals for human use. Validation of analytical procedures: Text and methodology Q2(R1). ICH, Geneva, Switzerland, (2005).

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 5 | Завантажень: 26 |